We are live on
!
Find out more
FA
Forefront Analytics Portfolio holdings
AUM
$110M
1-Year Est. Return
18.54%
This Fund
S&P 500
This Quarter
Est. Return
+3.91%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
–
AUM
$194M
AUM Growth
+$6.3M
(+3.4%)
Cap. Flow
+$740K
Cap. Flow
% of AUM
0.38%
Top 10 Holdings %
Top 10 Hldgs %
57.19%
Holding
81
New
6
Increased
31
Reduced
36
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares ESG Aware MSCI EAFE ETF
ESGD
|
+$19.2M |
| 2 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$674K |
| 3 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$669K |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$333K |
| 5 |
Thermo Fisher Scientific
TMO
|
+$268K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen ESG Large-Cap Value ETF
NULV
|
+$16M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$765K |
| 3 |
HDV
iShares Core High Dividend ETF
HDV
|
+$555K |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$453K |
| 5 |
iShares Currency Hedged MSCI Emerging Markets
HEEM
|
+$421K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.48% |
| 2 | Technology | 0.35% |
| 3 | Industrials | 0.26% |
| 4 | Financials | 0.23% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SURF
76
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $42.7K | 0.02% |
61,156
-2,200
| -3% | -$1.78K |
|
77
CytomX Therapeutics
CTMX
$788M
| $39.9K | 0.02% |
26,412
+1,625
| +7% | +$3.67K |
|
78
Nkarta
NKTX
$186M
| $37.2K | 0.02% |
+10,475
| New | +$49.6K |
|
|
CDAK
79
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $19.2K | 0.01% |
110,210
+10,275
| +10% | +$5.72K |
|
80
Dyadic International
DYAI
$45.9M
| – | – |
-57,094
| Closed | -$70.2K |
|
|
ADAM
81
Adamas Trust
ADAM
$807M
| – | – |
-2,500
| Closed | -$25.6K |
|
Similar funds
NC
PXPO
OWA
MCM
AC
NA
NMC
BCM
Forefront Analytics's Q1 2023 Portfolio in Review
As of Q1 2023, Forefront Analytics held 81 positions worth $194M, up 3.4% from $188M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Forefront Analytics's Q1 2023 filing shows 6 new, 31 increased, 36 reduced and 2 closed positions. Its largest new stake was iShares ESG Aware MSCI EAFE ETF: 273,342 shares worth $19.6M. The largest sale was Nuveen ESG Large-Cap Value ETF, an estimated $16M.
By sector, the portfolio is most concentrated in Healthcare at 1.5% of assets, up from 1.3% a quarter earlier, followed by Technology and Industrials.
- Forefront Analytics's largest Q1 2023 buy was iShares ESG Aware MSCI EAFE ETF: 273,342 shares worth $19.6M.
- Forefront Analytics added most to State Street SPDR Bloomberg Investment Grade Floating Rate ETF in Q1 2023, an estimated $674K increase.
- Forefront Analytics's biggest Q1 2023 reduction was Nuveen ESG Large-Cap Value ETF, cutting an estimated $16M.
- Forefront Analytics fully exited Dyadic International in Q1 2023, selling an estimated $70.2K.
- Forefront Analytics's ten largest holdings make up 57% of its $194M portfolio in Q1 2023.
- Forefront Analytics opened 6 new positions and closed 2 in Q1 2023.
- Forefront Analytics's portfolio value rose 3.4% quarter-over-quarter to $194M.
Based on Forefront Analytics's 13F filing for Q1 2023, filed 12 May 2023.